The Global CBD Gummies Market Will Reach $12 Billion by 2028

CBD gummies are often used by people who want to supplement with CBD but do not like the taste of the oils. The global CBD gummies market is expected to grow over the next six years due to the therapeutic effects of CBD and reducing the stigma of hemp. Analyst firm Research and Markets valued the global CBD jelly market at $2.1 billion in 2021 and projected it to reach $12.1 billion by 2028.

Driven by the widespread legalization of cannabis and increasing acceptance of cannabis use, the CBD gummies market is expected to grow at a compound annual growth rate (CAGR) of 28.3% from 2021 to 2028. CBD (cannabidiol) is the active ingredient in cannabis and according to the World Health Organization (WHO), it has no potential risk of abuse or addiction.

The CBD gummies market is mainly based on stationary hemp stores and online sales. Hemp stores held the largest market share in 2020, but Research and Markets expects the e-commerce segment to grow at the fastest rate by 2028.

CBD gummies of various brands are also available on e-commerce platforms such as Amazon.com. Such platforms have witnessed significant growth as they offer consumers home delivery, discounts, a wide range of products, and the ability to compare different products.

Read more about the CBD gummies market and find other important news in the cannabis sector with the Hemp.im mobile app. Cannabis is one of the world’s most talked-about topics and the Hemp.im cannabis news application focuses on the latest news, social change, economic trends, and medical information in the industry. As your official hemp news app, we also cover salient topics like the Hemp Farm Bill, the legality of hemp, the various health benefits of hemp as well as the multitude of products made from hemp

The global CBD jelly market was valued at $2.1 billion by 2021

Awareness of CBD’s health benefits has increased in recent years, including its use among athletes for better recovery and pain management. According to the report, in 2020. North America accounted for the largest share of the global CBD gummies market, although Europe is expected to see the fastest growth through 2028 due to a significant increase in the number of hemp consumers.

The European Union legalized CBD in November 2020, paving the way for increased potential for CBD gummies market growth across Europe. The report also revealed that CBD is increasingly being viewed as a new ingredient in food, beverages, and dietary supplements. These factors are expected to support the growth of the CBD gummies market across Europe in the coming years.

Manufacturers are focusing on lowering THC content and using pure and organic ingredients in CBD jelly, which is also expected to boost the market growth. According to Research and Markets, the leading players in the CBD gummies market are Aurora Cannabis Inc, Canopy Growth Corp., and CV Sciences, Inc.

__

(Featured image by Alex Vaz via Pexels)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in FAKTY KONOPNE.PL, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.